首页 › 慢性淋巴细胞白血病 › 俄亥俄州 › Cincinnati
Cincinnati OH 慢性淋巴细胞白血病临床试验
15项针对 慢性淋巴细胞白血病的研究正在 Cincinnati及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
招募中2 期
- Saint Elizabeth Medical Center Edgewood, Edgewood · 距离 8 英里
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
招募中4 期
- Oncology Hematology Care Inc, Cincinnati
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- 以及另外 3 项
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
招募中2 期
- University of Cincinnati, Cincinnati
- Oncology Hematology Care, Fairfield · 距离 15 英里
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
招募中3 期
- Oncology Hematology Care Clinical Trials, Llc, Cincinnati
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
招募中1 期
- University of Cincinnatti Medical Center, Cincinnati
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- University of Cincinnati Medical Center, Cincinnati
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
招募中3 期
- Saint Elizabeth Healthcare ( Site 0041), Edgewood · 距离 8 英里
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
招募中1 期
- University of Cincinnati, Cincinnati
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- University of Cincinnati Medical Center, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
招募中1 期
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
招募中2 期
- University of Cincinnati, Cincinnati
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
招募中2 期
- University of Cincinnati, Cincinnati
LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
招募中2 期
- University of Cincinnati Medical Center, Cincinnati
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
招募中1/2 期
- University of Cincinnati, Cincinnati
其他城市的 慢性淋巴细胞白血病试验
- Boston, MA31 项研究
- Columbus, OH29 项研究
- Durham, NC28 项研究
- Washington, DC22 项研究
- Seattle, WA22 项研究
- Rochester, MN20 项研究
- New York City, NY20 项研究
- Houston, TX18 项研究
- Baldwin Park, CA18 项研究
- Milwaukee, WI15 项研究
- Chicago, IL14 项研究
- Nashville, TN13 项研究
Cincinnati的其他研究
- 非小细胞肺癌31 项研究
- 癌症（所有类型）26 项研究
- 乳腺癌24 项研究
- 心力衰竭22 项研究
- 转移性癌症21 项研究
- 结直肠癌20 项研究
- 肥胖症20 项研究
- 急性髓系白血病20 项研究
- 前列腺癌19 项研究
- 卵巢癌18 项研究
- 肺癌18 项研究
- 多发性骨髓瘤17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。